Worldwide Healthcare Trust


£2014.3m market cap

3545p last close

Worldwide Healthcare Trust’s investment objective is to invest worldwide in pharmaceutical, biotechnology and related securities in the healthcare sector to achieve a high level of capital growth. Gearing and derivative transactions are used to mitigate risk and enhance capital returns.

Investment summary

Worldwide Healthcare Trust (WWH) is managed by Sven Borho and Trevor Polischuk at OrbiMed. They remain very constructive on the prospects for the global healthcare sector – despite headline risk ahead of the 2020 US presidential election – citing industry innovation, which they suggest is at ‘unparalleled’ levels, and has historically been an important driver of the sector’s performance. Although investor concerns about drug pricing in the US remain, Borho and Polischuk say that pharma and biotech companies are ‘still getting paid and are generating attractive returns’. In addition to opportunities in developed markets, they are also finding interesting investment ideas in China, due to higher product approval standards and a relaxation of listing requirements for fledgling companies.

Share price graph
Price performance
Actual 11.0 14.4 37.4
Relative* 0.2 21.4 52.9
52-week high/low 3610.0p/2210.0p
*% relative to local index
Key management
David Harris Chairman
Martin Smith Chairman
Sven H Borho Fund manager

You may also be interested in…